Processa Pharmaceuticals ... (PCSA)
0.50
-0.05 (-8.93%)
At close: Mar 03, 2025, 3:59 PM
0.49
-1.78%
After-hours: Mar 03, 2025, 04:00 PM EST
Processa Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 113.42K | 200.2K | 312.48K | 192.15K | 20K | 140K |
| Cost of Revenue | 222.00 | 27.53M | 12.13M | 15.14M | 877.9K | 630.09K | 1.86K | 1.38K | 125.88K | 113.25K | 188K | 133.25K | n/a | 150K |
| Gross Profit | -222 | -27.53M | -12.13M | -15.14M | -877.9K | -630.09K | -1.86K | 3.62K | -12.45K | 86.95K | 124.48K | 58.89K | 20K | -10K |
| Operating Income | -11.46M | -27.53M | -12.13M | -15.14M | -3.94M | -4.52M | -1.8M | 71.53K | 2.69M | -4.16M | -2.96M | -2.27M | -770K | -160K |
| Interest Income | n/a | 101.2K | 11.99K | 3.17K | 11.55K | 18.3K | 5.18K | n/a | 4.65K | 249.00 | 2.39K | 3.13K | n/a | n/a |
| Pretax Income | -11.12M | -27.42M | -11.96M | -15.41M | -3.96M | -4.67M | -1.86M | -337.18K | -2.98M | -4.53M | -3.07M | -2.44M | -940K | -160K |
| Net Income | -11.12M | -54.85M | -11.43M | -14.41M | -3.36M | -3.77M | -1.86M | -335.98K | -3.35M | -4.53M | -3.07M | -2.44M | -940K | -160K |
| Selling & General & Admin | 5.66M | 8.76M | 4.69M | 3.26M | 1.61M | 1.44M | 876.32K | 69.97K | 945.46K | 2.84M | 2.82M | 1.88M | 610K | 40K |
| Research & Development | 5.8M | 11.49M | 6.88M | 3.17M | 2.32M | 3.09M | 926.12K | 6.56K | 29.25K | 189.75K | 267.06K | 448.03K | 170K | 110K |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -69.97K | -945.46K | n/a | n/a | n/a | 10K | n/a |
| Operating Expenses | 11.46M | 20.26M | 11.57M | 6.44M | 3.94M | 4.52M | 1.8M | 76.53K | 974.71K | 3.03M | 3.09M | 2.33M | 790K | 150K |
| Interest Expense | n/a | n/a | 362.00 | 281.12K | 36.66K | 161.21K | 35.69K | 245.38K | 235.64K | 365.96K | 109.72K | 170.72K | -170K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 69.97K | 945.46K | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 11.46M | 20.26M | 11.57M | 6.44M | 3.94M | 4.52M | 1.8M | 76.53K | 1.1M | 3.15M | 3.27M | 2.46M | 790K | 300K |
| Income Tax | n/a | 27.42M | -530.61K | -1M | -602.72K | -902.8K | -18.19K | -1.2K | 100.00 | 100.00 | 50.00 | 181.00 | n/a | n/a |
| Shares Outstanding (Basic) | 1.31M | 805.46K | 765.97K | 374.98K | 275.87K | 266.61K | 232.83K | 11.24K | 11.24K | 9.04K | 5.14K | 4.09K | 8K | 8K |
| Shares Outstanding (Diluted) | 1.31M | 805.46K | 765.97K | 374.98K | 275.87K | 266.61K | 232.83K | 11.24K | 11.24K | 9.04K | 5.14K | 4.09K | 8K | 8K |
| EPS (Basic) | -8.48 | -68 | -15 | -38.4 | -12.17 | -14.2 | -8 | -29.8 | -298.4 | -500.8 | -597.8 | -676.69 | -20.4 | -3.4 |
| EPS (Diluted) | -8.48 | -68 | -15 | -38.4 | -12.17 | -14.2 | -8 | -29.8 | -298.4 | -500.8 | -597.8 | -676.69 | -20.4 | -3.4 |
| EBITDA | -11.46M | -19.47M | -11.08M | -5.63M | -3.05M | -3.88M | -1.8M | -337.18K | -2.51M | -2.94M | -2.54M | -2.16M | -1.11M | -160K |
| Depreciation & Amortization | 222.00 | 874.01K | 875.35K | 882.06K | 877.9K | 630.09K | 1.86K | 1.38K | 238.82K | 461.26K | 414.91K | 108.47K | -340K | n/a |